Viral and bacterial aetiologies of epithelial ovarian cancer

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 9, 2012, Pages 2311-2317

  Shanmughapriya, S ^a,c   Vasanthi, N ^a   SenthilKumar, G ^b   Vinodhini, K ^c   Natarajaseenivasan, K ^c   Das, B C ^d  

^a BHARATHIDASAN UNIVERSITY   (India)

^b Dr G Vishwanathan Hospital   (India)

^c Sch Life Sci Bharathidasan U   (India)

^d UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN B;

ADULT; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONFIDENCE INTERVAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; OVARY CARCINOMA; PAPILLOMAVIRUS INFECTION; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; VIRUS DNA CELL DNA INTERACTION;

ADULT; AGED; CHLAMYDIA TRACHOMATIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; LYMPHOGRANULOMA VENEREUM; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION;

EID: 84866419771     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1570-5     Document Type: Article

References (40)

1. Posadas EM, Davidson B, Kohn EC (2004) Proteomics and ovarian cancer: implications for diagnosis and treatment: a critical review of the recent literature. Curr Opin Oncol 16:478-484
2. Berchuck A, Heron KA, Carney ME, Lancaster JM, Fraser EG, Vinson VL, Deffenbaugh AM, Miron A, Marks JR, Futreal PA, Frank TS (1998) Frequency of germline and somatic BRCA1 mutations in ovarian cancer. Clin Cancer Res 4:2433-2437
3. Idahl A, Lundin E, Jurstrand M, Kumlin U, Elgh F, Ohlson N, Ottander U (2011) Chlamydia trachomatis and Mycoplasma genitalium plasma antibodies in relation to epithelial ovarian tumors. Infect Dis Obstet Gynecol 2011:824627. doi:10.1155/2011/824627
4. Moss SF, Blaser MJ (2005) Mechanisms of disease: inflammation and the origins of cancer. Nat Clin Pract Oncol 2:90-97
5. Koskela P, Anttila T, Bjørge T, Brunsvig A, Dillner J, Hakama M, Hakulinen T, Jellum E, Lehtinen M, Lenner P, Luostarinen T, Pukkala E, Saikku P, Thoresen S, Youngman L, Paavonen J (2000) Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer 85:35-39
6. Madeleine MM, Anttila T, Schwartz SM, Saikku P, Leinonen M, Carter JJ, Wurscher M, Johnson LG, Galloway DA, Daling JR (2007) Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors. Int J Cancer 120:650-655
7. Risch HA, Howe GR (1995) Pelvic inflammatory disease and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 4:447-451
8. Boom R, Sol CJA, Salimans MMM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J (1990) Rapid and simple method for purification of nucleic acids. J Clin Microbiol 28:495-503
9. Høgdall EVS, Kjaer SK, Blaakaer J, Christensen L, Glud E, Vuust J, Høgdall CK (2006) P53 mutations in tissue from Danish ovarian cancer patients: from the Danish "MALOVA" ovarian cancer study. Gynecol Oncol 100:76-82
10. Bauer HM, Greer CE, Manos MM (1992) Determination of genital HPV infection using consensus PCR. In: Herrington CS, McGee JOD (eds) Diagnostic molecular pathology: a practical approach. Oxford University Press, Oxford, pp 131-152
11. Bauer HM, Hildesheim A, Schiffman MH, Glass AG, Rush BB, Scott DR, Cadell DM, Kurman RJ,ManosMM(1993) Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Trans Dis 20:274-278
12. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ (1995) The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76:1057-1062
13. Mahony JB, Luinstra KE, Jang D, Sellors J, Chernesky MA (1992) Chlamydia trachomatis confirmatory testing of PCR-positive genitourinary specimens using a second set of plasmid primers. Mol Cell Probes 6:381-388
14. Kuhn DE, Beall CJ, Kolattukudy PE (1995) The cytomegalovirus US28 protein binds multiple CC chemokines with high affinity. Biochem Biophys Res Commun 211:325-330
15. Gupta J, Pilotti S, Rilke F, Shah K (1987) Association of human papillomavirus type 16 with neoplastic lesions of the vulva and other genital sites by in situ hybridization. Am J Pathol 127:206-215
16. Shah KV, Howley PM(1996) Papillomaviruses. In: Fields BN, Knipe DM, Howley PM (eds) Fields virology, vol 2. Lippincott-Raven, Philadelphia, pp 2077-2109
17. Dillner J, Lehtinen M, Björge T, Luostarinen T, Youngman L, Jellum E, Koskela P, Gislefoss RE, Hallmans G, Paavonen J, Sapp M, Schiller JT, Hakulinen T, Thoresen S, Hakama M (1997) Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. J Natl Cancer Inst 89:1293-1299
18. Runnebaum IB, Maier S, Tong XW, Rosenthal HE, Möbus VJ, Kieback DG, Kreienberg R (1995) Human papillomavirus integration is not associated with advanced epithelial ovarian cancer in German patients. Cancer Epidemiol Biomarkers Prev 4:573-575
19. Trottier AM, Provencher D, Mes-Masson AM, Vauclair R, Coutlée F (1995) Absence of human papillomavirus sequences in ovarian pathologies. J Clin Microbiol 33:1011-1013
20. Wu QJ, Guo M, Lu ZM, Li T, Qiao HZ, Ke Y (2003) Detection of human papillomavirus-16 in ovarian malignancy. Br J Cancer 89:672-675
21. Idahl A, Lundin E, Elgh F, Jurstrand M, Møller JK, Marklund I, Lindgren P, Ottander U (2010) Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, human papillomavirus, and polyomavirus are not detectable in human tissue with epithelial ovarian cancer, borderline tumor, or benign conditions. Am J Obstet Gynecol 202:71.e1-71.e6
22. Dürst M, Kleinheinz A, Hotz M, Gissmann L (1985) The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J Gen Virol 66:1515-1522
23. Galehouse D, Jenison E, DeLucia A (1992) Differences in the integration pattern and episomal forms of human papillomavirus type 16 DNA found within an invasive cervical neoplasm and its metastasis. Virology 186:339-341
24. Gissmann L, Wolnik L, Ikenberg H, Koldovsky U, Schnürch HG, zur Hausen H (1983) Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Nat Acad Sci USA 80:560-563
25. Boshart M, zur Hausen H (1986) Human papillomaviruses in Buschke-Löwenstein tumors: physical state of the DNA and identification of a tandem duplication in the noncoding region of a human papillomavirus 6 subtype. J Virol 58:963-966
26. Rando RF, Sedlacek TV, Hunt J, Jenson AB, Kurman RJ, Lancaster WD (1986) Verrucous carcinoma of the vulva associated with an unusual type 6 human papillomavirus. Obstet Gynecol 67:70S-75S
27. Byrne JC, Tsao MS, Fraser RS, Howley PM (1987) Human papillomavirus-11 DNA in a patient with chronic laryngotracheobronchial papillomatosis and metastatic squamous-cell carcinoma of the lung. N Engl J Med 317:873-878
28. Manias DA, Ostrow RS, Mcglennen RC, Estensen RD, Faras AJ (1989) Characterization of integrated human papillomavirus type 11 DNA in primary and metastatic tumors from a renal transplant recipient. Cancer Res 49:2514-2519
29. Bercovich JA, Centeno CR, Aguilar OG, Grinstein S, Kahn T (1991) Presence and integration of human papillomavirus type 6 in a tonsillar carcinoma. J Gen Virol 72:2569-2572
30. Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ, Hwang SY, Kim WY, Kim TJ, Lee JH, Kim BG, Bae DS (2008) Altered micro-RNA expression in cervical carcinomas. Clin Cancer Res 14:2535-2542
31. Mitao M, Reumann W, Winkler B, Richart RM, Fujiwara A, Crum CP (1984) Chlamydial cervicitis and cervical intraepithelial neoplasia: an immunohistochemical analysis. Gynecol Oncol 19:90-97
32. Kiviat NB, Paavonen JA, Brockway J, Critchlow CW, Brunham RC, Stevens CE, Stamm WE, Kuo CC, DeRouen T, Holmes KK (1985) Cytologic manifestations of cervical and vaginal infections. I. Epithelial and inflammatory cellular changes. JAMA 253:989-996
33. Fan T, LuH, Hu H, Shi L,McClarty GA, NanceDM, Greenberg AH, Zhong G (1998) Inhibition of apoptosis in Chlamydia-infected cells: blockade of mitochondrial cytochrome C release and caspase activation. J Exp Med 187:487-496
34. Felley-Bosco E (1998) Role of nitric oxide in genotoxicity: implication for carcinogenesis. Cancer Metastasis Rev 17:25-37
35. Castle PE,Hillier SL, Rabe LK, Hildesheim A,Herrero R, BrattiMC, Sherman ME, Burk RD, Rodriguez AC, Alfaro M, Hutchinson ML, Morales J, Schiffman M (2001) An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev 10:1021-1027
36. Prozialeck WC, Fay MJ, Lamar PC, Pearson CA, Sigar I, Ramsey KH (2002) Chlamydia trachomatis disrupts N-cadherin-dependent cell-cell junctions and sequesters beta-catenin in human cervical epithelial cells. Infect Immun 70:2605-2613
37. Sharma TM, Nadasdy T, Leech RW, Kingma DW, Johnson LD, Hanson-Painton O (1994) In situ DNA hybridization study of 'primary' cytomegalovirus (CMV) oophoritis. Acta Obstet Gynecol Scand 73:429-431
38. Manfredi R, Alampi G, Talò S, Calza L, Tadolini M, Martinelli GN, Chiodo F (2000) Silent oophoritis due to cytomegalovirus in a patient with advanced HIV disease. Int J STD AIDS 11:410-412
39. Yu J, Solano FX Jr, Seethala RR (2007) Bilateral cytomegalovirus (CMV) oophoritis mimicking widely metastatic carcinoma: a case report and review of the literature. Diagn Pathol 2:50
40. Hendrix RM, Wagenaar M, Slobbe RL, Bruggeman CA (1997) Widespread presence of cytomegalovirus DNA in tissues of healthy trauma victims. J Clin Pathol 50:59-63